NBC News, CNN: Company reports Alzheimer's drug study data
UC researcher says impact was small, recommends 'cautious optimism'
Japanese drugmaker Eisai recently reported cognitive decline was slowed by 27% after 18 months for patients with early-stage Alzheimer's who were given experimental drug lecanemab. The results have not yet been peer-reviewed.
The University of Cincinnati's Alberto Espay, MD, was not involved in the trial and provided his expert analysis to NBC News and CNN. He said the benefit to patients was "small" and fell below the threshold of what would be considered meaningful to a patient, but added that "patients can view this with cautious optimism."
Espay, professor of neurology in the UC College of Medicine, director and endowed chair of the James J. and Joan A. Gardner Family Center for Parkinson’s Disease and Movement Disorders at the UC Gardner Neuroscience Institute and a UC Health physician, said that while the results appear to be positive, the single trial is unlikely to prove that amyloid plaques are responsible for the decline in mental function often seen in patients.
Espay argues that amyloid plaques are a “consequence, not a cause” of Alzheimer’s disease. Cognitive impairment, he said, could be due to a decline in levels of a specific brain protein called amyloid-beta peptide, which then leads to the accumulation of amyloid plaques in the brain.
Featured photo at top courtesy of Unsplash.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Position-specific helmets may not improve protection
March 16, 2026
Local 12 highlighted a new study by biomedical engineering researchers that looked at how well new football helmets protected players from impacts that can cause concussions.
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.